← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Osel, Inc.
Santa Clara, CA
$16,900,761
Total funding
20
Grants
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,900,761 · 20
By mechanism
R44$5,556,863 · 3
U19$5,109,540 · 4
U01$2,314,110 · 1
R43$1,660,816 · 9
R33$1,475,086 · 1
R21$784,346 · 2
Investigators at Osel, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Lactobacilli as a Delivery Vehicle for Microbicides$1,463,248
U19 · FY2006 · AI
Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies$1,388,546
R44 · FY2015 · AI
Lactobacilli as a Delivery Vehicle for Microbicides$1,345,292
U19 · FY2005 · AI
Delivery of passive immunity against HIV using commensal vaginal Lactobacillus bioengineered to secrete broadly neutralizing domain antibodies$1,335,502
R44 · FY2014 · AI
Lactobacilli as a Delivery Vehicle for Microbicides$1,330,931
U19 · FY2007 · AI
Lactobacilli as a Delivery Vehicle for Microbicides$1,090,934
U19 · FY2004 · AI
MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial$1,000,000
R44 · FY2020 · AI
Neutralization of HIV by Modified Lactobacilli$758,296
R44 · FY2003 · AI
Anti-ICAM-i scFv from lactobacilli as a Microbicide$648,424
U19 · FY2006 · AI
Neutralization of HIV by Modified Lactobacilli$610,836
R44 · FY2002 · AI
MucoCept: a Live Topical Microbicide for Women$599,760
U01 · FY2005 · AI
MucoCept: a Live Topical Microbicide for Women$583,184
U01 · FY2006 · AI
Anti-ICAM-i scFv from lactobacilli as a Microbicide$575,937
U19 · FY2007 · AI
MucoCept: a Live Topical Microbicide for Women$574,751
U01 · FY2007 · AI
MucoCept: a Live Topical Microbicide for Women$556,415
U01 · FY2008 · AI
Anti-ICAM-i scFv from lactobacilli as a Microbicide$514,609
U19 · FY2005 · AI
Anti-ICAM-i scFv from lactobacilli as a Microbicide$472,078
U19 · FY2004 · AI
MucoCept-CVN, a genetically enhanced vaginal Lactobacillus strain for the prevention of HIV acquisition in women: Finalization of formulation for the first-in-human clinical trial$463,683
R44 · FY2021 · AI
Development of a Live Topical Microbicide for Women$425,654
R33 · FY2010 · AI
Development of a Live Topical Microbicide for Women$364,466
R33 · FY2011 · AI